We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+46.38%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$177M
AUM Growth
-$23.1M
Cap. Flow
-$42.9M
Cap. Flow %
-24.17%
Top 10 Hldgs %
54.35%
Holding
88
New
28
Increased
3
Reduced
8
Closed
48

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$12.7M
2
SOFI icon
SoFi Technologies
SOFI
+$11.1M
3
ULS icon
UL Solutions
ULS
+$10.4M
4
INSM icon
Insmed
INSM
+$9.12M
5
SLDB icon
Solid Biosciences
SLDB
+$7.32M

Top Sells

Rank Stock Value
1
FWDI
Forward Industries Inc
FWDI
+$10.4M
2
FIGR
Figure Technology Solutions
FIGR
+$7.27M
3
NTSK
Netskope Inc
NTSK
+$6.82M
4
BBIO icon
BridgeBio Pharma
BBIO
+$6.56M
5
CRBG icon
Corebridge Financial
CRBG
+$6.41M

Sector Composition

Rank Sector Weight
1 Healthcare 63.26%
2 Industrials 15.21%
3 Financials 10.28%
4 Technology 5.52%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
26
Dyne Therapeutics
DYN
$4.9B
$2.24M 1.26%
+114,525
New +$2.17M
WYFI
27
WhiteFiber Inc
WYFI
$951M
$2.21M 1.25%
140,000
-215,000
-61% -$5.32M
AERO
28
Grupo Aeromexico SAB de CV
AERO
$2.32B
$2.01M 1.13%
+91,619
New +$1.76M
EVAC.U
29
EQV Ventures Acquisition Corp II Units
EVAC.U
$2M 1.13%
198,313
-26,687
-12% -$270K
KYTX icon
30
Kyverna Therapeutics
KYTX
$484M
$1.83M 1.03%
+195,000
New +$1.45M
IMTX icon
31
Immatics
IMTX
$1.32B
$1.68M 0.95%
+160,336
New +$1.62M
CTNM
32
Contineum Therapeutics
CTNM
$566M
$1.57M 0.89%
+137,430
New +$1.57M
DNLI icon
33
Denali Therapeutics
DNLI
$3.97B
$1.51M 0.85%
+91,620
New +$1.55M
VERA icon
34
Vera Therapeutics
VERA
$2.36B
$1.16M 0.65%
+22,905
New +$814K
LPTH icon
35
Lightpath Technologies
LPTH
$820M
$1.08M 0.61%
+100,000
New +$810K
BDSX icon
36
Biodesix
BDSX
$248M
$764K 0.43%
112,344
+12,348
+12% +$90.9K
TARA icon
37
Protara Therapeutics
TARA
$232M
$666K 0.38%
+125,000
New +$695K
IMA
38
ImageneBio Inc
IMA
$64.6M
$632K 0.36%
+91,621
New +$679K
IBIO icon
39
iBio
IBIO
$70M
$530K 0.3%
+274,862
New +$375K
AMLX icon
40
Amylyx Pharmaceuticals
AMLX
$2.54B
– –
-30,000
Closed -$408K
BTBT icon
41
Bit Digital
BTBT
$482M
– –
-1,500,000
Closed -$4.5M
CIFR icon
42
Cipher Digital
CIFR
$7.13B
– –
-150,000
Closed -$1.89M
CRBG icon
43
Corebridge Financial
CRBG
$15B
– –
-200,000
Closed -$6.41M
CTRE icon
44
CareTrust REIT
CTRE
$9.74B
– –
-60,000
Closed -$2.08M
FWDI
45
Forward Industries Inc
FWDI
$319M
– –
-405,406
Closed -$10.4M
FOX icon
46
Fox Class B
FOX
$23.9B
– –
-70,000
Closed -$4.01M
HLLY icon
47
Holley
HLLY
$384M
– –
-350,000
Closed -$1.1M
IMRX icon
48
Immuneering
IMRX
$292M
– –
-300,000
Closed -$2.1M
KVYO icon
49
Klaviyo
KVYO
$4.73B
– –
-40,000
Closed -$1.11M
MIR icon
50
Mirion Technologies
MIR
$3.91B
– –
-100,000
Closed -$2.33M
1
2
3 4

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, Monashee Investment Management held 88 positions worth $177M, down 12% from $201M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Monashee Investment Management withdrew a net $42.9M in Q4 2025, closing 48 positions and reducing 8 holdings. Its most notable exit was Forward Industries Inc, an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 22% a quarter earlier, followed by Industrials and Financials.

Against the trend, Monashee Investment Management opened a new position in Medline Inc worth $12.6M.

  • Monashee Investment Management's largest Q4 2025 buy was Medline Inc: 300,000 shares worth $12.6M.
  • Monashee Investment Management added most to Miami International Holdings in Q4 2025, an estimated $1.11M increase.
  • Monashee Investment Management's biggest Q4 2025 reduction was BridgeBio Pharma, cutting an estimated $6.56M.
  • Monashee Investment Management fully exited Forward Industries Inc in Q4 2025, selling an estimated $10.4M.
  • Monashee Investment Management's ten largest holdings make up 54% of its $177M portfolio in Q4 2025.
  • Monashee Investment Management opened 28 new positions and closed 48 in Q4 2025.
  • Monashee Investment Management's portfolio value fell 12% quarter-over-quarter to $177M.

Based on Monashee Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.